June 5, 2026

Biogen’s salanersen gains FDA breakthrough therapy designation for SMA

​Biogen has received the breakthrough therapy designation from the FDA for salanersen (BIIB115), an investigational treatment for SMA.The post Biogen’s...

June 4, 2026

Insulet launches algorithm improvements for Omnipod 5 AID system in US

​Insulet has begun distributing an updated version of its Omnipod 5 AID System across the US, following 510(k) clearance in...

June 4, 2026

J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study

​J&J has reported that its monoclonal antibody, nipocalimab, met the primary endpoint in the Phase II JASMINE study by reducing...

June 4, 2026

Regeneron and CytomX extend cancer therapy partnership to $4bn deal

​Regeneron Pharmaceuticals and CytomX have expanded their research and licensing partnership to develop conditionally activated bispecific antibody cancer therapies.The post...

June 3, 2026

Moonlight begins SURVEYOR Phase I trial for peanut allergy

​Moonlight Therapeutics has begun the SURVEYOR Phase I clinical trial to assess MOON101, an investigational immunotherapy for peanut allergy.The post...

June 3, 2026

Roche’s giredestrant secures FDA priority review for breast cancer

​The US FDA has accepted priority review of the NDA for Roche’s investigational oral SERD, giredestrant, for breast cancer.The post...

June 3, 2026

Philips secures FDA clearance for Elevate Plus AI ultrasound upgrade

​Philips has received 510(k) clearance for Elevate Plus, which adds imaging and AI capabilities to its EPIQ Elite and Affiniti...

June 2, 2026

Jade reports interim Phase I results of JADE101 for IgAN

​Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-APRIL monoclonal antibody for...

June 2, 2026

MicroPort launches LBBOT Solution commercially in Europe and Australia

​MicroPort CardioFlow has commercially launched its LBBOT Solution in Europe and Australia after obtaining the required regulatory approvals.The post MicroPort...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.